2.06MMarket Cap-199P/E (TTM)
1.0900High1.0900Low987Volume1.0900Open1.0800Pre Close1.08KTurnover0.06%Turnover RatioLossP/E (Static)1.89MShares7.750052wk High-1.66P/B1.94MFloat Cap0.980152wk Low--Dividend TTM1.78MShs Float216.1500Historical High--Div YieldTTM0.00%Amplitude0.9801Historical Low1.0900Avg Price1Lot Size
IMAC Holdings Stock Forum
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
IMAC Holdings (NASDAQ: BACK) has received a deficiency notification from Nasdaq due to its failure to timely file its Q3 2024 Form 10-Q. The company now has until January 21, 2024, to submit a compliance plan. If Nasdaq accepts the plan, IMAC may receive up to 180 calendar days (until May 19, 2025) to regain compliance. While the notice has no imme...
IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1)
IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology
IMAC Holdings Inc. (Nasdaq: BACK) has launched a new subsidiary, Ignite Proteomics , introducing a groundbreaking precision oncology assay for breast cancer treatment using Reverse Phase Protein Array (RPPA) technology. This follows IMAC's acquisition of key assets from Theralink Technologies, Inc. A landmark clinical case stud...
900k float, and 25k on level ll
900k float, and 25k on level ll
$IMAC Holdings (BACK.US)$ $Intellicheck (IDN.US)$ $Digital World Acquisition Corp (DWAC.US)$ $FOXO Technologies (FOXO.US)$ $Femto Technologies (BCAN.US)$ $Flora Growth (FLGC.US)$
📊⚡️📊
A quick recap for the weekend ending March 24, 2024.
Eight stocks with >30% YTD
$Latham Group (SWIM.US)$38.40%
$DoubleDown Interactive (DDI.US)$67.63%
$Hippo Holdings (HIPO.US)$88.93%
$Vaxart (VXRT.US)$119.97%
$Ocugen (OCGN.US)$185.22%
$BeyondSpring (BYSI.US)$246.67%
$Vincerx Pharma (VINC.US)$325.42%
$Airship AI (AISP.US)$452.94%
Top 5 Gainers (22 Mar 2024)
$Murano Global Investments (MRNO.US)$120.89% ...
No comment yet